SHOVLIN ROBERT J. 4
4 · NEOGENOMICS INC · Filed Aug 3, 2020
Insider Transaction Report
Form 4
SHOVLIN ROBERT J.
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2020-07-30$7.52/sh+66,667$501,336→ 212,902 total - Sale
Common Stock
2020-07-30$38.17/sh−81,356$3,105,359→ 148,270 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-07-30−66,667→ 0 totalExercise: $7.52Exp: 2022-04-28→ Common Stock (66,667 underlying) - Exercise/Conversion
Common Stock
2020-07-30$19.60/sh+16,724$327,790→ 229,626 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-07-30−16,724→ 50,173 totalExercise: $19.60Exp: 2024-03-01→ Common Stock (16,724 underlying)
Holdings
- 56,271
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (56,271 underlying) - 96,167
Stock Option (Right to Buy)
Exercise: $8.03Exp: 2023-02-26→ Common Stock (96,167 underlying)
Footnotes (4)
- [F1]On April 28, 2017, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F2]On March 1, 2019, Mr. Shovlin was granted 66,897 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F3]On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F4]On March 2, 2020, Mr. Shovlin was granted 56,271 stock options. These options vest ratably over the first four anniversary dates of the grant date.